Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Grammas, Paula
Martinez, Joseph
and
Miller, Bradley
2011.
Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases.
Expert Reviews in Molecular Medicine,
Vol. 13,
Issue. ,
Wang, Tianli
Agarwal, Sagar
and
Elmquist, William F.
2012.
Brain Distribution of Cediranib Is Limited by Active Efflux at the Blood-Brain Barrier.
Journal of Pharmacology and Experimental Therapeutics,
Vol. 341,
Issue. 2,
p.
386.
Ren, Jinfeng
Shen, Shun
Wang, Dangge
Xi, Zhangjie
Guo, Liangran
Pang, Zhiqing
Qian, Yong
Sun, Xiyang
and
Jiang, Xinguo
2012.
The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2.
Biomaterials,
Vol. 33,
Issue. 11,
p.
3324.
Bode, Julia
Veenman, Leo
Caballero, Beatriz
Lakomek, Max
Kugler, Wilfried
and
Gavish, Moshe
2012.
The 18 kDa translocator protein influences angiogenesis, as well as aggressiveness, adhesion, migration, and proliferation of glioblastoma cells.
Pharmacogenetics and Genomics,
Vol. 22,
Issue. 7,
p.
538.
Kundu, Paromita
Mohanty, Chandana
and
Sahoo, Sanjeeb K.
2012.
Retraction notice to ‘‘Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy’’ [Acta Biomaterialia 8 (2012) 2670–2687].
Acta Biomaterialia,
Vol. 8,
Issue. 7,
p.
2670.
Gao, Huile
Qian, Jun
Cao, Shijie
Yang, Zhi
Pang, Zhiqing
Pan, Shuaiqi
Fan, Li
Xi, Zhangjie
Jiang, Xinguo
and
Zhang, Qizhi
2012.
Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles.
Biomaterials,
Vol. 33,
Issue. 20,
p.
5115.
Serwer, Laura P.
and
James, C. David
2012.
Challenges in drug delivery to tumors of the central nervous system: An overview of pharmacological and surgical considerations.
Advanced Drug Delivery Reviews,
Vol. 64,
Issue. 7,
p.
590.
Li, Yan
He, Hai
Jia, Xinru
Lu, Wan-Liang
Lou, Jinning
and
Wei, Yen
2012.
A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.
Biomaterials,
Vol. 33,
Issue. 15,
p.
3899.
Gao, Huile
Qian, Jun
Yang, Zhi
Pang, Zhiqing
Xi, Zhangjie
Cao, Shijie
Wang, Yuchen
Pan, Shuaiqi
Zhang, Shuang
Wang, Wei
Jiang, Xinguo
and
Zhang, Qizhi
2012.
Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)-poly(ε-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy.
Biomaterials,
Vol. 33,
Issue. 26,
p.
6264.
Pham, Kien
Luo, Defang
Liu, Che
and
Harrison, Jeffrey K.
2012.
CCL5, CCR1 and CCR5 in murine glioblastoma: Immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5.
Journal of Neuroimmunology,
Vol. 246,
Issue. 1-2,
p.
10.
Agarwal, Sagar
Mittapalli, Rajendar K.
Zellmer, David M.
Gallardo, Jose L.
Donelson, Randy
Seiler, Charlie
Decker, Stacy A.
SantaCruz, Karen S.
Pokorny, Jenny L.
Sarkaria, Jann N.
Elmquist, William F.
and
Ohlfest, John R.
2012.
Active Efflux of Dasatinib from the Brain Limits Efficacy against Murine Glioblastoma: Broad Implications for the Clinical Use of Molecularly Targeted Agents.
Molecular Cancer Therapeutics,
Vol. 11,
Issue. 10,
p.
2183.
Sane, Ramola
Agarwal, Sagar
and
Elmquist, William F.
2012.
Brain Distribution and Bioavailability of Elacridar after Different Routes of Administration in the Mouse.
Drug Metabolism and Disposition,
Vol. 40,
Issue. 8,
p.
1612.
Ruzevick, Jacob
Jackson, Christopher
Phallen, Jillian
and
Lim, Michael
2012.
Clinical Trials with Immunotherapy for High-Grade Glioma.
Neurosurgery Clinics of North America,
Vol. 23,
Issue. 3,
p.
459.
Zhang, Bo
Sun, Xiyang
Mei, Heng
Wang, Yu
Liao, Ziwei
Chen, Jun
Zhang, Qizhi
Hu, Yu
Pang, Zhiqing
and
Jiang, Xinguo
2013.
LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
Biomaterials,
Vol. 34,
Issue. 36,
p.
9171.
Gao, Huile
Yang, Zhi
Zhang, Shuang
Cao, Shijie
Shen, Shun
Pang, Zhiqing
and
Jiang, Xinguo
2013.
Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization.
Scientific Reports,
Vol. 3,
Issue. 1,
Muhic, Aida
Poulsen, Hans Skovgaard
Sorensen, Morten
Grunnet, Kirsten
and
Lassen, Ulrik
2013.
Phase II open-label study of nintedanib in patients with recurrent glioblastoma multiforme.
Journal of Neuro-Oncology,
Vol. 111,
Issue. 2,
p.
205.
St-Coeur, Patrick-Denis
Touaibia, Mohamed
Cuperlovic-Culf, Miroslava
and
Morin, Pier Jr
2013.
Leveraging Metabolomics to Assess the Next Generation of Temozolomide-Based Therapeutic Approaches for Glioblastomas.
Genomics, Proteomics & Bioinformatics,
Vol. 11,
Issue. 4,
p.
199.
Chacko, Ann-Marie
Li, Chunsheng
Pryma, Daniel A
Brem, Steven
Coukos, George
and
Muzykantov, Vladimir
2013.
Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood–brain barrier divide.
Expert Opinion on Drug Delivery,
Vol. 10,
Issue. 7,
p.
907.
Lin, Fan
Marchetti, Serena
Pluim, Dick
Iusuf, Dilek
Mazzanti, Roberto
Schellens, Jan H.M.
Beijnen, Jos H.
and
van Tellingen, Olaf
2013.
Abcc4 Together with Abcb1 and Abcg2 Form a Robust Cooperative Drug Efflux System That Restricts the Brain Entry of Camptothecin Analogues.
Clinical Cancer Research,
Vol. 19,
Issue. 8,
p.
2084.
Siegal, T.
2013.
Which drug or drug delivery system can change clinical practice for brain tumor therapy?.
Neuro-Oncology,
Vol. 15,
Issue. 6,
p.
656.